These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 36295854)

  • 1. Serum Bile Acid Profiling and Mixed Model Analysis Reveal Biomarkers Associated with Pruritus Reduction in Maralixibat-Treated Patients with BSEP Deficiency.
    Zhao X; Zhang W; Vig P; Kostrub C; Setchell KDR
    Metabolites; 2022 Oct; 12(10):. PubMed ID: 36295854
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Maralixibat in progressive familial intrahepatic cholestasis (MARCH-PFIC): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial.
    Miethke AG; Moukarzel A; Porta G; Covarrubias Esquer J; Czubkowski P; Ordonez F; Mosca A; Aqul AA; Squires RH; Sokal E; D'Agostino D; Baumann U; D'Antiga L; Kasi N; Laborde N; Arikan C; Lin CH; Gilmour S; Mittal N; Chiou FK; Horslen SP; Huber WD; Jaecklin T; Nunes T; Lascau A; Longpre L; Mogul DB; Garner W; Vig P; Hupertz VF; Gonzalez-Peralta RP; Ekong U; Hartley J; Laverdure N; Ovchinsky N; Thompson RJ
    Lancet Gastroenterol Hepatol; 2024 Jul; 9(7):620-631. PubMed ID: 38723644
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Maralixibat for the treatment of PFIC: Long-term, IBAT inhibition in an open-label, Phase 2 study.
    Loomes KM; Squires RH; Kelly D; Rajwal S; Soufi N; Lachaux A; Jankowska I; Mack C; Setchell KDR; Karthikeyan P; Kennedy C; Dorenbaum A; Desai NK; Garner W; Jaecklin T; Vig P; Miethke A; Thompson RJ
    Hepatol Commun; 2022 Sep; 6(9):2379-2390. PubMed ID: 35507739
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of maralixibat treatment in patients with Alagille syndrome and cholestatic pruritus (ICONIC): a randomised phase 2 study.
    Gonzales E; Hardikar W; Stormon M; Baker A; Hierro L; Gliwicz D; Lacaille F; Lachaux A; Sturm E; Setchell KDR; Kennedy C; Dorenbaum A; Steinmetz J; Desai NK; Wardle AJ; Garner W; Vig P; Jaecklin T; Sokal EM; Jacquemin E
    Lancet; 2021 Oct; 398(10311):1581-1592. PubMed ID: 34755627
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Partial external biliary diversion in bile salt export pump deficiency: Association between outcome and mutation.
    Ellinger P; Stindt J; Dröge C; Sattler K; Stross C; Kluge S; Herebian D; Smits SHJ; Burdelski M; Schulz-Jürgensen S; Ballauff A; Schulte Am Esch J; Mayatepek E; Häussinger D; Kubitz R; Schmitt L
    World J Gastroenterol; 2017 Aug; 23(29):5295-5303. PubMed ID: 28839429
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety, tolerability, and efficacy of maralixibat in adults with primary sclerosing cholangitis: Open-label pilot study.
    Bowlus CL; Eksteen B; Cheung AC; Thorburn D; Moylan CA; Pockros PJ; Forman LM; Dorenbaum A; Hirschfield GM; Kennedy C; Jaecklin T; McKibben A; Chien E; Baek M; Vig P; Levy C
    Hepatol Commun; 2023 Jun; 7(6):. PubMed ID: 37184523
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resolution of Pruritus in a Child With Alagille Syndrome Treated With Maralixibat for Seven Years: Durable Response and Discontinuation of Other Medications.
    Garcia A; Hsu E; Lin HC
    JPGN Rep; 2023 Aug; 4(3):e335. PubMed ID: 37600618
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Placebo-Controlled Randomized Trial of an Intestinal Bile Salt Transport Inhibitor for Pruritus in Alagille Syndrome.
    Shneider BL; Spino C; Kamath BM; Magee JC; Bass LM; Setchell KD; Miethke A; Molleston JP; Mack CL; Squires RH; Murray KF; Loomes KM; Rosenthal P; Karpen SJ; Leung DH; Guthery SL; Thomas D; Sherker AH; Sokol RJ;
    Hepatol Commun; 2018 Oct; 2(10):1184-1198. PubMed ID: 30288474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictors of 6-year event-free survival in Alagille syndrome patients treated with maralixibat, an ileal bile acid transporter inhibitor.
    Sokol RJ; Gonzales EM; Kamath BM; Baker A; Vig P; Mogul DB; Garner W; Hansen BE; Jacquemin E; Thompson RJ
    Hepatology; 2023 Dec; 78(6):1698-1710. PubMed ID: 37278241
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of long-term administration of maralixibat on children with cholestasis secondary to Alagille syndrome.
    Shneider BL; Spino CA; Kamath BM; Magee JC; Ignacio RV; Huang S; Horslen SP; Molleston JP; Miethke AG; Kohli R; Leung DH; Jensen MK; Loomes KM; Karpen SJ; Mack C; Rosenthal P; Squires RH; Baker A; Rajwal S; Kelly D; Sokol RJ; Thompson RJ;
    Hepatol Commun; 2022 Aug; 6(8):1922-1933. PubMed ID: 35672955
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic preconditioning protects BSEP/ABCB11
    Fuchs CD; Paumgartner G; Wahlström A; Schwabl P; Reiberger T; Leditznig N; Stojakovic T; Rohr-Udilova N; Chiba P; Marschall HU; Trauner M
    J Hepatol; 2017 Jan; 66(1):95-101. PubMed ID: 27593105
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genotype-phenotype relationships of truncating mutations, p.E297G and p.D482G in bile salt export pump deficiency.
    Felzen A; van Wessel DBE; Gonzales E; Thompson RJ; Jankowska I; Shneider BL; Sokal E; Grammatikopoulos T; Kadaristiana A; Jacquemin E; Spraul A; Lipiński P; Czubkowski P; Rock N; Shagrani M; Broering D; Nicastro E; Kelly D; Nebbia G; Arnell H; Fischler B; Hulscher JBF; Serranti D; Arikan C; Polat E; Debray D; Lacaille F; Goncalves C; Hierro L; Muñoz Bartolo G; Mozer-Glassberg Y; Azaz A; Brecelj J; Dezsőfi A; Calvo PL; Grabhorn E; Hartleif S; van der Woerd WJ; Kamath BM; Wang JS; Li L; Durmaz Ö; Kerkar N; Jørgensen MH; Fischer R; Jimenez-Rivera C; Alam S; Cananzi M; Laverdure N; Ferreira CT; Guerrero FO; Wang H; Sency V; Kim KM; Chen HL; de Carvalho E; Fabre A; Bernabeu JQ; Zellos A; Alonso EM; Sokol RJ; Suchy FJ; Loomes KM; McKiernan PJ; Rosenthal P; Turmelle Y; Horslen S; Schwarz K; Bezerra JA; Wang K; Hansen BE; Verkade HJ;
    JHEP Rep; 2023 Feb; 5(2):100626. PubMed ID: 36687469
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MYO5B and bile salt export pump contribute to cholestatic liver disorder in microvillous inclusion disease.
    Girard M; Lacaille F; Verkarre V; Mategot R; Feldmann G; Grodet A; Sauvat F; Irtan S; Davit-Spraul A; Jacquemin E; Ruemmele F; Rainteau D; Goulet O; Colomb V; Chardot C; Henrion-Caude A; Debray D
    Hepatology; 2014 Jul; 60(1):301-10. PubMed ID: 24375397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical outcomes of surgical management for rare types of progressive familial intrahepatic cholestasis: a case series.
    Masahata K; Ueno T; Bessho K; Kodama T; Tsukada R; Saka R; Tazuke Y; Miyagawa S; Okuyama H
    Surg Case Rep; 2022 Jan; 8(1):10. PubMed ID: 35024979
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Covert Surge: Murine Bile Acid Levels Are Associated With Pruritus in Pediatric Autoimmune Sclerosing Cholangitis.
    Meinel K; Szabo D; Dezsofi A; Pohl S; Strini T; Greimel T; Aguiriano-Moser V; Haidl H; Wagner M; Schlagenhauf A; Jahnel J
    Front Pediatr; 2022; 10():903360. PubMed ID: 35633951
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unraveling the Relationship Between Itching, Scratch Scales, and Biomarkers in Children With Alagille Syndrome.
    Kamath BM; Spino C; McLain R; Magee JC; Fredericks EM; Setchell KD; Miethke A; Molleston JP; Mack CL; Squires RH; Alonso EM; Murray KF; Loomes KM; Kyle Jensen M; Karpen SJ; Rosenthal P; Thomas D; Sokol RJ; Shneider BL;
    Hepatol Commun; 2020 Jul; 4(7):1012-1018. PubMed ID: 32626833
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatocanalicular bile salt export pump deficiency in patients with progressive familial intrahepatic cholestasis.
    Jansen PL; Strautnieks SS; Jacquemin E; Hadchouel M; Sokal EM; Hooiveld GJ; Koning JH; De Jager-Krikken A; Kuipers F; Stellaard F; Bijleveld CM; Gouw A; Van Goor H; Thompson RJ; Müller M
    Gastroenterology; 1999 Dec; 117(6):1370-9. PubMed ID: 10579978
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum Autotaxin Activity Correlates With Pruritus in Pediatric Cholestatic Disorders.
    Kremer AE; Gonzales E; Schaap FG; Oude Elferink RP; Jacquemin E; Beuers U
    J Pediatr Gastroenterol Nutr; 2016 Apr; 62(4):530-5. PubMed ID: 26628447
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel mutation within a transmembrane helix of the bile salt export pump (BSEP, ABCB11) with delayed development of cirrhosis.
    Stindt J; Ellinger P; Weissenberger K; Dröge C; Herebian D; Mayatepek E; Homey B; Braun S; Schulte am Esch J; Horacek M; Canbay A; Schmitt L; Häussinger D; Kubitz R
    Liver Int; 2013 Nov; 33(10):1527-35. PubMed ID: 23758865
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progressive familial intrahepatic cholestasis.
    Jacquemin E
    Clin Res Hepatol Gastroenterol; 2012 Sep; 36 Suppl 1():S26-35. PubMed ID: 23141890
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.